Literature DB >> 16352342

The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys.

Hester E de Melker1, Florens G A Versteegh, Joop F P Schellekens, Peter F M Teunis, Mirjam Kretzschmar.   

Abstract

OBJECTIVES: Bordetella pertussis circulates even in highly vaccinated populations. There is a considerable amount of infection in adults. For designing more effective vaccination schedules it is important to quantify the age-dependent relation between the number of notified cases and the number of infections.
METHODS: We used a statistical relationship between the time since infection and the IgG antibody titers against pertussis toxin, derived from a longitudinal data set, to estimate time since infection for all individuals in a cross-sectional population-based study (1995-1996) based on their titers. Age-specific incidence of infection with B. pertussis was calculated and compared with the age-distribution of notified cases of pertussis in 1994-1996.
RESULTS: Estimated incidence of infection was 6.6% per year for 3-79-year olds, annual incidence of notified cases 0.01%. Estimated age-specific incidence of infection was lowest for 3-4-year olds (3.3%) and increased gradually up to the age of 20-24 years (10.8%). The number of notified cases was highest for 3-9-year olds.
CONCLUSIONS: In the Dutch population B. pertussis infections occur more frequently and in elder age-categories then suggested by notifications. Mathematical modeling could explore what booster vaccination strategies are most effective in reducing severe disease among not (completely) vaccinated infants.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16352342     DOI: 10.1016/j.jinf.2005.10.020

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  55 in total

Review 1.  The pertussis enigma: reconciling epidemiology, immunology and evolution.

Authors:  Matthieu Domenech de Cellès; Felicia M G Magpantay; Aaron A King; Pejman Rohani
Journal:  Proc Biol Sci       Date:  2016-01-13       Impact factor: 5.349

2.  Sero-epidemiology as a tool to study the incidence of Salmonella infections in humans.

Authors:  J Simonsen; M A Strid; K Mølbak; K A Krogfelt; A Linneberg; P Teunis
Journal:  Epidemiol Infect       Date:  2007-08-03       Impact factor: 2.451

3.  Interleukin-1 receptor signaling is required to overcome the effects of pertussis toxin and for efficient infection- or vaccination-induced immunity against Bordetella pertussis.

Authors:  Xuqing Zhang; Sara E Hester; Mary J Kennett; Alexia T Karanikas; Liron Bendor; David E Place; Eric T Harvill
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

4.  Recent findings on pertussis epidemiology in Turkey.

Authors:  D Dilli; I Bostanci; Y Dallar; T Buzgan; H Irmak; M A Torunoğlu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-01-09       Impact factor: 3.267

5.  The RNA chaperone Hfq is required for virulence of Bordetella pertussis.

Authors:  Ilona Bibova; Karolina Skopova; Jiri Masin; Ondrej Cerny; David Hot; Peter Sebo; Branislav Vecerek
Journal:  Infect Immun       Date:  2013-08-26       Impact factor: 3.441

6.  Immunization of teenagers with a fifth dose of reduced DTaP-IPV induces high levels of pertussis antibodies with a significant increase in opsonophagocytic activity.

Authors:  Audun Aase; Tove Karin Herstad; Samuel Merino; Merete Bolstad; Synne Sandbu; Hilde Bakke; Ingeborg S Aaberge
Journal:  Clin Vaccine Immunol       Date:  2011-06-15

7.  Brief Report: Seroprevalence of Pertussis Infection in HIV-Infected Adults in the United States.

Authors:  Stephanie B Troy; Alexandria E-B Rossheim; DaShaunda D Hilliard; Tina D Cunningham
Journal:  J Acquir Immune Defic Syndr       Date:  2016-11-01       Impact factor: 3.731

8.  Decline of IgG pertussis toxin measured in umbilical cord blood, and neonatal and early infant serum.

Authors:  L C S Smallenburg; N A van Welie; L H Elvers; J C M van Huisseling; P F M Teunis; F G A Versteegh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-04-23       Impact factor: 3.267

9.  O antigen allows B. parapertussis to evade B. pertussis vaccine-induced immunity by blocking binding and functions of cross-reactive antibodies.

Authors:  Xuqing Zhang; Maria Eugenia Rodríguez; Eric T Harvill
Journal:  PLoS One       Date:  2009-09-14       Impact factor: 3.240

10.  Incidence and reproduction numbers of pertussis: estimates from serological and social contact data in five European countries.

Authors:  Mirjam Kretzschmar; Peter F M Teunis; Richard G Pebody
Journal:  PLoS Med       Date:  2010-06-22       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.